Prom1 Mouse shRNA Plasmid (Locus ID 19126)
CAT#: TL501745
Prom1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | Prom1 Mouse shRNA Plasmid (Locus ID 19126) |
Locus ID | 19126 |
UniProt ID | O54990 |
Synonyms | 4932416E19Rik; AC133; CD133; Prom; Prom-1; Proml1 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | Prom1 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 19126). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | BC028286, NM_001163577, NM_001163578, NM_001163581, NM_001163582, NM_001163583, NM_001163584, NM_001163585, NM_008935, NM_001163585.1, NM_008935.1, NM_008935.2, NM_001163577.1, NM_001163578.1, NM_001163581.1, NM_001163582.1, NM_001163583.1, NM_001163584.1 |
Summary | May play a role in cell differentiation, proliferation and apoptosis. Binds cholesterol in cholesterol-containing plasma membrane microdomains and may play a role in the organization of the apical plasma membrane in epithelial cells. During early retinal development acts as a key regulator of disk morphogenesis (PubMed:19228982). Involved in regulation of MAPK and Akt signaling pathways. In neuroblastoma cells suppresses cell differentiation such as neurite outgrowth in a RET-dependent manner.[UniProtKB/Swiss-Prot Function] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
,Roy, L;Bobbs, A;Sattler, R;Kurkewich, JL;Dausinas, PB;Nallathamby, P;Cowden Dahl, KD;,
Cancer Growth Metastasis
,PubMed ID 29662326
[PROM1]
|
Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells.
,null,
Oncology reports
,PubMed ID 26370320
[Prom1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...